Titan Pharmaceuticals, Inc. (TTNP)

Titan Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	5	6	11	10	22	11
Market Cap Growth	-56.87%	-45.93%	13.29%	-53.14%	100.13%	-37.99%
Enterprise Value	-1	-1	9	4	17	10
PE Ratio	-	-1.11	-1.12	-1.15	-1.18	-0.65
PS Ratio	57.06	33.66	20.57	6.63	4.46	4.14
PB Ratio	0.82	0.93	8.40	1.97	6.11	7.52
P/FCF Ratio	-0.89	-0.87	-1.40	-1.28	-1.22	-0.69
P/OCF Ratio	-0.93	-0.87	-1.40	-1.28	-1.25	-0.70
EV/Sales Ratio	-8.62	-5.51	15.28	2.67	3.51	3.84
EV/EBITDA Ratio	0.15	0.19	-0.85	-0.48	-0.99	-0.66
EV/EBIT Ratio	0.15	0.18	-0.83	-0.46	-0.97	-0.65
EV/FCF Ratio	0.12	0.14	-1.04	-0.51	-0.96	-0.64
Debt / Equity Ratio	0.01	0.09	0.14	0.06	0.23	3.10
Debt / EBITDA Ratio	-0.01	-0.10	-0.02	-0.03	-0.05	-0.29
Debt / FCF Ratio	-0.01	-0.08	-0.02	-0.04	-0.05	-0.28
Quick Ratio	11.26	5.41	1.20	2.41	1.49	1.57
Current Ratio	11.83	5.55	1.37	2.71	1.74	2.31
Asset Turnover	0.01	0.04	0.08	0.14	0.50	0.32
Interest Coverage	-169.83	-	-	-	-22.72	-16.02
Return on Equity (ROE)	-99.90%	-165.90%	-221.10%	-111.90%	-770.40%	-5237.20%
Return on Assets (ROA)	-77.60%	-105.70%	-140.90%	-81.70%	-186.50%	-199.30%
Return on Capital (ROIC)	-108.55%	-100.97%	-660.32%	-172.04%	-169.34%	-134.08%
Earnings Yield	-99.79%	-89.91%	-89.09%	-86.78%	-84.54%	-152.64%
FCF Yield	-121.59%	-114.53%	-71.43%	-78.34%	-82.23%	-145.62%
Buyback Yield / Dilution	-13.58%	-11.90%	-38.13%	-157.88%	-392.56%	-304.01%
Total Shareholder Return	-13.58%	-11.90%	-38.13%	-157.88%	-392.56%	-304.01%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).